Phospholipase A2 Receptor Antibody PLA2R Qualitative Test
Comprehensive Introduction to PLA2R Antibody Testing
The Phospholipase A2 Receptor Antibody PLA2R Qualitative Test represents a groundbreaking advancement in nephrology diagnostics, specifically designed to detect autoantibodies that target the phospholipase A2 receptor in kidney tissues. This sophisticated immunological test has revolutionized the diagnosis and management of membranous nephropathy, providing clinicians with a highly specific biomarker for autoimmune kidney disorders. The identification of PLA2R antibodies has transformed our understanding of kidney autoimmune diseases and offers patients a precise diagnostic pathway for appropriate treatment planning.
What the Test Measures and Detects
This specialized qualitative test specifically detects the presence of autoantibodies directed against the M-type phospholipase A2 receptor (PLA2R) using advanced immunofluorescence assay (IFA) methodology. The test measures:
- Autoantibodies targeting the PLA2R antigen in kidney glomeruli
- Immunological markers associated with primary membranous nephropathy
- Specific IgG4 subclass antibodies that characterize autoimmune kidney disease
- Biomarkers that differentiate primary from secondary forms of membranous nephropathy
Who Should Consider This Test
This test is particularly recommended for individuals experiencing:
- Unexplained proteinuria or elevated urine protein levels
- Nephrotic syndrome symptoms including edema and swelling
- Unexplained kidney function decline
- Suspected autoimmune kidney disorders
- Patients with risk factors for membranous nephropathy
- Individuals with family history of autoimmune kidney conditions
Clinical Benefits of PLA2R Antibody Testing
Undergoing the Phospholipase A2 Receptor Antibody test provides numerous clinical advantages:
- Accurate Diagnosis: Provides definitive confirmation of primary membranous nephropathy
- Treatment Guidance: Helps nephrologists develop targeted immunosuppressive therapy plans
- Disease Monitoring: Enables tracking of disease activity and treatment response
- Prognostic Information: Assists in predicting disease course and potential outcomes
- Early Intervention: Facilitates timely treatment to prevent progressive kidney damage
Understanding Your Test Results
Your test results will be interpreted by our expert nephrology team:
- Positive Result: Indicates the presence of PLA2R antibodies, strongly suggesting primary membranous nephropathy
- Negative Result: Suggests alternative causes for kidney symptoms or secondary forms of membranous nephropathy
- Clinical Correlation: Results are interpreted in context with clinical presentation and other laboratory findings
- Follow-up Recommendations: Detailed guidance on next steps and potential additional testing
Test Pricing and Availability
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Phospholipase A2 Receptor Antibody PLA2R Qualitative Test | $150 USD | $226 USD |
Nationwide Testing Availability
GGC DNA Diagnostics maintains comprehensive testing facilities across the United States, with convenient locations in major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our network ensures accessible testing for patients nationwide.
Schedule Your Test Today
Take control of your kidney health with our advanced Phospholipase A2 Receptor Antibody testing. Our specialized immunopathology department, led by experienced nephrologists, provides accurate diagnostic services with rapid turnaround times. Samples submitted by 9 am on Tuesday or Friday receive same-day results, ensuring prompt clinical decision-making.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your test or to speak with our kidney health specialists. Early detection and accurate diagnosis are crucial for preserving kidney function and maintaining overall health.
